Elo Life Systems, launched in 2021 and based in North Carolina, is an ingredient company developing plant-based sweeteners, proteins, natural preservatives, flavors and bioactive compounds. Its first product, a monk fruit–derived natural sweetener the company says is 300 times sweeter than sugar without calories, is slated to launch in 2026. Elo Life leverages molecular farming, gene‑editing and precision fermentation to produce the sweetener in easier-to-grow crops such as watermelons and sugar beets to reduce cost and carbon footprint. The company has partnerships including with Dole to create a fungal‑resistant Cavendish banana and with a large NGO to improve staple crops like cassava and cowpea in developing countries. After three years focused on R&D, Elo plans to spend the next two years building supply chains, engaging growers and processors, working with ingredient companies and securing regulatory approvals ahead of commercialization. Financially, Elo has raised $45 million in venture-backed capital to date. Elo Life Systems develops a monk‑fruit‑inspired high‑intensity sweetener and Cavendish bananas engineered to resist Fusarium wilt using a proprietary gene‑editing platform called ARCUS and other breeding technologies. The company produces the sweetener pathway in scalable plant systems (currently a watermelon variety) and is exploring additional expression hosts such as sorghum, sugar beet and tomatoes. Elo is partnering with Dole to send disease‑resistant banana varieties to field trials in Honduras and aims to assess field resistance, yield and quality by the end of the next season. The sweetener is claimed to be 200–300× sweeter than sucrose with high mogroside V purity and is undergoing the FDA GRAS process, targeting market entry in 2025. Elo was spun out of Precision Bio in December 2021 and is based in North Carolina. The company plans to open a Series B later this year to further scale the sweetener and expand its R&D pipeline, and it recently appointed Joan Braca as an independent director.

Total raised

$45M

Funding rounds

2

Latest round

Series A

Latest activity

Jan 2024